British Columbia Investment Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-40,845
Closed -$7.5M 849
2021
Q2
$7.5M Buy
40,845
+4,882
+14% +$897K 0.05% 338
2021
Q1
$5.5M Sell
35,963
-1,154
-3% -$176K 0.04% 366
2020
Q4
$5.8M Sell
37,117
-1,182
-3% -$185K 0.04% 344
2020
Q3
$4.38M Buy
38,299
+2,820
+8% +$323K 0.04% 370
2020
Q2
$3.98M Buy
35,479
+11,273
+47% +$1.27M 0.04% 356
2020
Q1
$2.17M Sell
24,206
-28,631
-54% -$2.57M 0.04% 347
2019
Q4
$5.71M Buy
52,837
+22,156
+72% +$2.4M 0.04% 335
2019
Q3
$3.01M Sell
30,681
-71,685
-70% -$7.02M 0.03% 465
2019
Q2
$13.4M Buy
102,366
+4,328
+4% +$567K 0.12% 174
2019
Q1
$13.3M Buy
98,038
+41,906
+75% +$5.66M 0.12% 171
2018
Q4
$5.47M Buy
56,132
+7,235
+15% +$704K 0.05% 392
2018
Q3
$6.8M Sell
48,897
-50,936
-51% -$7.08M 0.07% 320
2018
Q2
$12.4M Buy
99,833
+15,785
+19% +$1.96M 0.11% 214
2018
Q1
$9.37M Sell
84,048
-19,206
-19% -$2.14M 0.07% 318
2017
Q4
$12.3M Buy
103,254
+8,997
+10% +$1.08M 0.09% 269
2017
Q3
$13.2M Sell
94,257
-69,384
-42% -$9.73M 0.1% 241
2017
Q2
$19.9M Sell
163,641
-40,232
-20% -$4.89M 0.16% 164
2017
Q1
$24.7M Buy
203,873
+52,600
+35% +$6.38M 0.2% 120
2016
Q4
$18.5M Buy
151,273
+16,492
+12% +$2.02M 0.16% 146
2016
Q3
$16.5M Sell
134,781
-16,255
-11% -$1.99M 0.17% 144
2016
Q2
$17.6M Buy
151,036
+1,046
+0.7% +$122K 0.15% 149
2016
Q1
$20.9M Buy
149,990
+26,692
+22% +$3.72M 0.2% 121
2015
Q4
$23.5M Sell
123,298
-28,769
-19% -$5.49M 0.23% 105
2015
Q3
$23.8M Sell
152,067
-1,699
-1% -$266K 0.24% 101
2015
Q2
$27.8M Buy
153,766
+12,999
+9% +$2.35M 0.26% 93
2015
Q1
$24.4M Buy
140,767
+11,297
+9% +$1.96M 0.22% 117
2014
Q4
$24M Buy
129,470
+4,532
+4% +$839K 0.2% 130
2014
Q3
$20.7M Sell
124,938
-8,058
-6% -$1.34M 0.17% 146
2014
Q2
$20.8M Sell
132,996
-4,293
-3% -$671K 0.17% 156
2014
Q1
$20.9M Sell
137,289
-12,053
-8% -$1.83M 0.18% 150
2013
Q4
$19.8M Buy
149,342
+35,778
+32% +$4.75M 0.16% 166
2013
Q3
$13.2M Sell
113,564
-4,911
-4% -$570K 0.11% 221
2013
Q2
$10.9M Buy
+118,475
New +$10.9M 0.09% 262